The Department brings together a globally-recognised, multidisciplinary group comprising scientists, academic clinicians and research facilitators to develop innovative technologies and translate them into clinical practice. Our portfolio of platform technologies spans manufacture of biomaterials, biological applications of nanotechnology and tissue engineering, with applications to the clinic enabled by evidence based healthcare and clinical trials. Our aim is to drive uptake of innovative treatments and improve surgical practice to enhance patient benefit.
This Research Department brings together clinicians and scientists from a variety of backgrounds, who are working together to develop highly targeted novel imaging, sensing, management and energy based interventions to detect and cure disease.
SITU specialises in providing infrastructure for running studies led by surgeons and interventionists within any anatomical site and has a long history of managing large scale multi-centre, multinational randomised controlled clinical trials in solid tumours.